Premium
P1‐066: Amyloid β oligomers as a potential biomarker for early—stage Alzheimer's disease
Author(s) -
Bruggink Kim,
Kuiperij H. Bea,
Verbeek Marcel M.
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.345
Subject(s) - biomarker , monomer , monoclonal antibody , oligomer , amyloid (mycology) , cerebrospinal fluid , chemistry , fibril , alzheimer's disease , dementia , antibody , microbiology and biotechnology , extracellular , mutant , disease , biochemistry , medicine , pathology , biology , immunology , gene , organic chemistry , polymer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom